March 25

AMA-JAMA to Investigate Following AHRP Complaint

ama_logo.jpg

 

 

FOR IMMEDIATE RELEASE                                                        March 27, 2009

AMA REQUESTS JOURNAL OVERSIGHT COMMITTEE REVIEW

Statement attributable to: Joseph M. Heyman, M.D.
AMA Board Chair

 

"The American Medical Association is owner and publisher of the Journal of the American Medical Association (JAMA) and its specialty Archives journals. While we are ultimately responsible for these publications, as most in the medical and journalism professions are aware, these journals are editorially independent of AMA. That means we do not review or interfere in what is printed in these journals.

"Recently, concerns have been raised over how JAMA editors addressed a conflict of interest issue   brought to light by Professor Jonathan Leo. As owner and publisher of JAMA, we take these concerns very seriously.

"In accordance with the Editorial Governance Plan for JAMA, this entire matter is being formally referred to the Journal Oversight Committee (JOC). The AMA is requesting that the JOC examine the concerns related to Professor Leo’s inquiry and upon completion present its findings to the AMA Board of Trustees. The AMA Board will give careful consideration to whatever is reported to it by the JOC."

  ###

Contact:
AMA Media Relations
(312) 464-4430                                                                      

AHRP Letter of Complaint 


Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.


You may also like

January 26, 2023

The last generation of Holocaust survivors and their children express their concerns about current events A Five-Part

Read More
Vera Sharav’s documentary “Never Again is Now Global” premieres Monday January 30 on CHD-TV

October 26, 2022

FDA Advisory Panel & CDC Director are Complicit in Sacrificing Children’s Lives to Protect Pfizer from Liability 

Read More
FDA Advisory Panel & CDC Director are Complicit in Sacrificing Children’s Lives to Protect Pfizer from Liability